- Home
- MULN vs CLDI Comparison
MULN vs CLDI Comparison
Compare MULN & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MULN
- CLDI
- Stock Information
- Founded
- MULN 2014
- CLDI 2014
- Country
- MULN United States
- CLDI United States
- Employees
- MULN N/A
- CLDI N/A
- Industry
- MULN Auto Manufacturing
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MULN Consumer Discretionary
- CLDI Health Care
- Exchange
- MULN Nasdaq
- CLDI Nasdaq
- Market Cap
- MULN 15.1M
- CLDI 18.1M
- IPO Year
- MULN N/A
- CLDI N/A
- Fundamental
- Price
- MULN $1.32
- CLDI $1.47
- Analyst Decision
- MULN
- CLDI Strong Buy
- Analyst Count
- MULN 0
- CLDI 3
- Target Price
- MULN N/A
- CLDI $16.67
- AVG Volume (30 Days)
- MULN 2.1M
- CLDI 1.2M
- Earning Date
- MULN 02-11-2025
- CLDI 11-12-2024
- Dividend Yield
- MULN N/A
- CLDI N/A
- EPS Growth
- MULN N/A
- CLDI N/A
- EPS
- MULN N/A
- CLDI N/A
- Revenue
- MULN $156,570.00
- CLDI N/A
- Revenue This Year
- MULN N/A
- CLDI N/A
- Revenue Next Year
- MULN N/A
- CLDI N/A
- P/E Ratio
- MULN N/A
- CLDI N/A
- Revenue Growth
- MULN N/A
- CLDI N/A
- 52 Week Low
- MULN $1.21
- CLDI $0.73
- 52 Week High
- MULN $1,870.00
- CLDI $18.50
- Technical
- Relative Strength Index (RSI)
- MULN 29.41
- CLDI 37.87
- Support Level
- MULN $2.11
- CLDI $1.60
- Resistance Level
- MULN $1.93
- CLDI $2.17
- Average True Range (ATR)
- MULN 0.23
- CLDI 0.20
- MACD
- MULN -0.01
- CLDI -0.08
- Stochastic Oscillator
- MULN 6.75
- CLDI 5.37
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.